Skip to main content

Acute coronary syndrome patients benefit from platelet glycoprotein IIb/IIIa inhibition as part of an initially medical treatment strategy: Results of a meta-analysis of phase III randomized trials.

Publication ,  Journal Article
Boersma, E; Harrington, RA; Van de Werf, FV; Armstrong, PW; Simes, J; Hasselblad, V; Simoons, ML
Published in: CIRCULATION
October 23, 2001

Duke Scholars

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 23, 2001

Volume

104

Issue

17

Start / End Page

782 / 782

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Boersma, E., Harrington, R. A., Van de Werf, F. V., Armstrong, P. W., Simes, J., Hasselblad, V., & Simoons, M. L. (2001). Acute coronary syndrome patients benefit from platelet glycoprotein IIb/IIIa inhibition as part of an initially medical treatment strategy: Results of a meta-analysis of phase III randomized trials. CIRCULATION, 104(17), 782–782.
Boersma, E., R. A. Harrington, F. V. Van de Werf, P. W. Armstrong, J. Simes, V. Hasselblad, and M. L. Simoons. “Acute coronary syndrome patients benefit from platelet glycoprotein IIb/IIIa inhibition as part of an initially medical treatment strategy: Results of a meta-analysis of phase III randomized trials.CIRCULATION 104, no. 17 (October 23, 2001): 782–782.
Boersma E, Harrington RA, Van de Werf FV, Armstrong PW, Simes J, Hasselblad V, Simoons ML. Acute coronary syndrome patients benefit from platelet glycoprotein IIb/IIIa inhibition as part of an initially medical treatment strategy: Results of a meta-analysis of phase III randomized trials. CIRCULATION. LIPPINCOTT WILLIAMS & WILKINS; 2001 Oct 23;104(17):782–782.

Published In

CIRCULATION

ISSN

0009-7322

Publication Date

October 23, 2001

Volume

104

Issue

17

Start / End Page

782 / 782

Publisher

LIPPINCOTT WILLIAMS & WILKINS

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology